Search

Your search keyword '"Wierzbicki AS"' showing total 1,034 results

Search Constraints

Start Over You searched for: Author "Wierzbicki AS" Remove constraint Author: "Wierzbicki AS" Publisher elsevier bv Remove constraint Publisher: elsevier bv
1,034 results on '"Wierzbicki AS"'

Search Results

2. A novel gain-of-function phosphorylation site modulates PTPN22 inhibition of TCR signaling

4. Validation of the familial chylomicronaemia syndrome (FCS) score in an ethnically diverse cohort from UK FCS registry: Implications for diagnosis and differentiation from multifactorial chylomicronaemia syndrome (MCS)

9. Layered Na2Mn3O7 decorated by Cerium as the robust catalysts for efficient low temperature soot combustion

13. Determinants of lipid clinic referral and attendance in a multi-ethnic adult population in south London: a cross-sectional study

16. Long-Term Toxicity in Patients Receiving Radiotherapy for Ultracentral Stage I Non-Small Cell Lung Cancer – A Secondary Analysis of the LUSTRE Randomized Trial

17. 128 Long-Term Toxicity in Patients Receiving Radiotherapy for Ultracentral Stage I Non-Small Cell Lung Cancer - A Secondary Analysis of the Lustre Randomized Trial

18. Corrigendum to “Synthesis of low-molecular weight itaconic acid polymers as nanoclay dispersants and dispersion stabilizers” [Polymer 265 (2023) 125614–125622]

22. Familial chylomicronaemia syndrome (FCS) score validation in United Kingdom FCS registry: Can additional variables improve the FCS score performance?

24. Natural history of familial chylomicronaemia syndrome (FCS) compared to multifactorial chylomicronaemia syndrome (MCS) - Initial analysis from united kingdom fcs registry

26. Long-term effects of volanesorsen on triglycerides and pancreatitis in patients with familial chylomicronaemia syndrome (FCS) in the UK Early Access to Medicines Scheme (EAMS)

27. Fructose-1,6-bisphosphatase is a nonenzymatic safety valve that curtails AKT activation to prevent insulin hyperresponsiveness

29. Investigation of hospital discharge cases and SARS-CoV-2 introduction into Lothian care homes

30. From crystal phase mixture to pure metal-organic frameworks – Tuning pore and structure properties

31. Fructose-1,6-bisphosphatase is a nonenzymatic safety valve that curtails AKT activation to prevent insulin hyperresponsiveness

35. The current treatment trends and survival patterns in melanoma patients with positive sentinel lymph node biopsy (SLNB): a multicenter nationwide study

39. The ectonucleotidase CD39 identifies tumor-reactive CD8+ T cells predictive of immune checkpoint blockade efficacy in human lung cancer

40. Investigation of Cu promotion effect on hydrotalcite-based nickel catalyst for CO2 methanation

41. LUSTRE: A Phase III Randomized Trial of Stereotactic Body Radiotherapy (SBRT) vs. Conventionally Hypofractionated Radiotherapy (CRT) for Medically Inoperable Stage I Non-Small Cell Lung Cancer (NSCLC)

42. City-wide wastewater genomic surveillance through the successive emergence of SARS-CoV-2 Alpha and Delta variants

43. City-wide wastewater genomic surveillance through the successive emergence of SARS-CoV-2 Alpha and Delta variants

44. Lung SBRT credentialing in the Canadian OCOG-LUSTRE randomized trial

46. Investigation of off-design characteristics of solid oxide electrolyser (SOE) operating in endothermic conditions

47. LUSTRE: A Phase III Randomized Trial of Stereotactic Body Radiotherapy (SBRT) vs. Conventionally Hypofractionated Radiotherapy (CRT) for Medically Inoperable Stage I Non-Small Cell Lung Cancer (NSCLC)

48. Vanadium promoted Ni(Mg,Al)O hydrotalcite-derived catalysts for CO2 methanation

Catalog

Books, media, physical & digital resources